Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cyrus, Zabetian"'
Autor:
Thiago P Leal, Jennifer N French-Kwawu, Mateus H Gouveia, Victor Borda, Miguel Inca-Martinez, Emily A Mason, Andrea RVR Horimoto, Douglas P Loesch, Elif I Sarihan, Mario R Cornejo-Olivas, Luis E Torres, Pilar E Mazzetti-Soler, Carlos Cosentino, Elison H Sarapura-Castro, Andrea Rivera-Valdivia, Angel C Medina, Elena M Dieguez, Víctor E Raggio, Andrés Lescano, Vitor Tumas, Vanderci Borges, Henrique B Ferraz, Carlos R Rieder, Artur Schumacher-Schuh, Bruno L Santos-Lobato, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Francisco Lopera, Sonia Moreno, Pedro Chana-Cuevas, William Fernandez, Gonzalo Arboleda, Humberto Arboleda, Carlos E Arboleda Bustos, Dora Yearout, Maria F Lima-Costa, Eduardo Tarazona, Cyrus Zabetian, Timothy A Thornton, Timothy D O’Connor, Ignacio F Mata
Publikováno v:
medRxiv
Sex differences in Parkinson Disease (PD) risk are well-known. However, it is still unclear the role of sex chromosomes in the development and progression of PD. We performed the first X-chromosome Wide Association Study (XWAS) for PD risk in Latin A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611448199f677e7660d221b8a0d775d6
https://europepmc.org/articles/PMC9915833/
https://europepmc.org/articles/PMC9915833/
Autor:
Nathan Hwangbo, Xinyu Zhang, Daniel Raftery, Haiwei Gu, Shu-Ching Hu, Thomas J. Montine, Joseph F. Quinn, Kathryn A. Chung, Amie L. Hiller, Dongfang Wang, Qiang Fei, Lisa Bettcher, Cyrus Zabetian, Elaine R. Peskind, Ge Li, Daniel Promislow, Marie Y. Davis, Alexander Franks
Publikováno v:
Metabolites, vol 12, iss 4
In recent years, metabolomics has been used as a powerful tool to better understand the physiology of neurodegenerative diseases and identify potential biomarkers for progression. We used targeted and untargeted aqueous, and lipidomic profiles of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b87624ac8476273c45689f17e833b83
Autor:
Christine R, Swanson, Katherine, Li, Travis L, Unger, Michael D, Gallagher, Vivianna M, Van Deerlin, Pinky, Agarwal, James, Leverenz, John, Roberts, Ali, Samii, Rachel Goldmann, Gross, Howard, Hurtig, Jacqueline, Rick, Daniel, Weintraub, John Q, Trojanowski, Cyrus, Zabetian, Alice S, Chen-Plotkin
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 30(6)
The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson's disease (PD). Here, we explore the role of plasma apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promot
Autor:
Lynn Bekris, Debby Tsuang, James Leverenz, Chang‐En Yu, Oscar Lopez, Ronald Hamilton, David Bennett, Eric Larson, Paul Crane, Jeffrey Kaye, John Trojanowski, Aron Buchman, Patricia Kramer, Randy Woltjer, Julie Schneider, Daniel Weintraub, Alice Chen‐Plotkin, Peter Nelson, Gregory Jicha, Gerard Schellenberg, Walter Kulkull, Stennis Watson, Douglas Galasko, Eliezer Masliah, Joseph Quinn, Kathryn Chung, Dora Yearout, Ignacio Mata, Karen Edwards, Thomas Montine, Cyrus Zabetian
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
Judy K, Qiang, Yvette C, Wong, Andrew, Siderowf, Howard I, Hurtig, Sharon X, Xie, Virginia M-Y, Lee, John Q, Trojanowski, Dora, Yearout, James, B Leverenz, Thomas J, Montine, Matt, Stern, Susan, Mendick, Danna, Jennings, Cyrus, Zabetian, Ken, Marek, Alice S, Chen-Plotkin
Publikováno v:
Annals of neurology. 74(1)
To identify plasma-based biomarkers for Parkinson disease (PD) risk.In a discovery cohort of 152 PD patients, plasma levels of 96 proteins were measured by multiplex immunoassay; proteins associated with age at PD onset were identified by linear regr
Autor:
James B. Leverenz, Cyrus Zabetian, Ellen J. Steinbart, Kate Nickel, Malia Rumbaugh, Thomas J. Montine, Thomas D. Bird
Publikováno v:
Alzheimer's & Dementia. 6
Autor:
James B, Leverenz, Joseph F, Quinn, Cyrus, Zabetian, Jing, Zhang, Kathleen S, Montine, Thomas J, Montine
Publikováno v:
Current topics in medicinal chemistry. 9(10)
Parkinson disease (PD) is an already prevalent neurodegenerative disease that is poised to at least double over the next 25 years. Although best known for its characteristic movement disorder, PD is now appreciated commonly to cause cognitive impairm
Autor:
Sheng Pan, Jing Zhang, John Rush, Elaine R. Peskind, Douglas Galasko, Kathryn Chung, Joseph Quinn, Joseph Jankovic, James B. Leverenz, Cyrus Zabetian, Catherine Pan, Yan Wang, Jung Hun Oh, Jean Gao, Jianpeng Zhang, Thomas Montine
Publikováno v:
Journal of Proteome Research; Jan2008, Vol. 7 Issue 2, p720-730, 11p
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::37c2a6f53cc564f2aa9fb7c0624be31a
http://europepmc.org/abstract/med/19754405
http://europepmc.org/abstract/med/19754405